Sovereign AI and trusted research environments are quietly reshaping how pharma companies access and analyze data.

Women’s sports organizations support their athletes’ health and fitness to extend their careers, but research is limited on ...

At recent CRN conference, USANA chief scientific officer Kathryn Armstrong says the firm uses six-point check list to ...

The FDA retired the Chief Information Officer title, but Sanjay Sahoo moved to temporarily lead the new Office of Mission ...

As China’s new cosmetics safety standard starts a compliance clock for brands, cosmetic chemist Kelly Dobos explains in an ...

The PD-1 blocking immunotherapy is the first approved treatment in a subset of rectal cancer patients, building on one ...

Data from the ARC-20 platform study drive optimism for the Phase III program as the company touts favorable efficacy numbers ...

A white paper on “Digitally Derived Measures” stresses that the process of incorporating them into clinical trials must start ...

Oncology leaders say they’ve learned how to better design and differentiate newer versions of antibody-drug conjugates ...

EMA supports dropping the prescription requirement for Mundipharma’s Nyxoid, but each EU state will decide where it is sold.

A Sandoz patent challenge to Amneal’s Crexont has been voluntarily dismissed without prejudice, but an Alembic suit heads to ...

The UK wants to change the way medtech companies interact with its medical regulator via a more transparent process and ...